Acid-sensing ion channel 3 blockade inhibits durovascular and nitric oxide-mediated trigeminal pain.
Christopher M HoltonLauren C StrotherIsaac DrippsAmynah Amir Ali PradhanPeter J GoadsbyPhilip Robert HollandPublished in: British journal of pharmacology (2020)
These results support the development of specific ASIC3 or combined ASIC1/3 blockers for migraine-related pain and point to a potential role for ASIC-dependent NO-mediated attack triggering. This has key implications for migraine, given the major unmet need for novel therapeutic targets.